Peer Review reports
From: Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma
| Original Submission | ||
|---|---|---|
| 9 Sep 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 7 Jan 2023 | Reviewed | Reviewer Report - Maria González-cao |
| 18 Jan 2023 | Reviewed | Reviewer Report - Marcin Ziętek |
| 8 Feb 2023 | Author responded | Author comments - Douglas Johnson |
| Resubmission - Version 4 | ||
| 8 Feb 2023 | Submitted | Manuscript version 4 |
| 17 Feb 2023 | Author responded | Author comments - Douglas Johnson |
| Resubmission - Version 5 | ||
| 17 Feb 2023 | Submitted | Manuscript version 5 |
| 24 Feb 2023 | Author responded | Author comments - Douglas Johnson |
| Resubmission - Version 6 | ||
| 24 Feb 2023 | Submitted | Manuscript version 6 |
| 27 Feb 2023 | Author responded | Author comments - Douglas Johnson |
| Resubmission - Version 7 | ||
| 27 Feb 2023 | Submitted | Manuscript version 7 |
| 2 Mar 2023 | Reviewed | Reviewer Report - Maria González-cao |
| Resubmission - Version 8 | ||
| Submitted | Manuscript version 8 | |
| Publishing | ||
| 6 Mar 2023 | Editorially accepted | |
| 23 Mar 2023 | Article published | 10.1186/s12885-023-10708-6 |
You can find further information about peer review here.